Ananthakrishnan will retire in the beginning of 2017 and Vivek Vasudev Kamath will assume role of Managing Director Designate from December 16, 2016, MSD in India said in a statement.
Vivek joined MSD in India in July 2012 and is currently the Business Unit Director for Cardiovascular Metabolics and Market Access, it added.
"MSD has a robust succession planning process through which Vivek was identified to lead MSD in India and to deliver on our commitment to patients and communities in the country," MSD President Asia Pacific Region Jan Van Acker said.
Disclaimer: No Business Standard Journalist was involved in creation of this content